Table 2.
Neuropsychological test scores.
| Cognitive scores | Baseline | Post treatment (stage 2) |
|---|---|---|
| Screening tests | ||
| MMSE | 18.11 (3.9) | 21.6 (3.4) |
| MoCA | 14.4 (2.7) | 15.00 (4.1) |
| Attention | ||
| Digit span forward | 3.60 (1.5) | 3.40 (0.8) |
| Digit span backward | 2.80 (0.4) | 2.80 (1.3) |
| Memory | ||
| Verbal memory (CERAD) | ||
| Short term | 2.80 (1.9) | 4.60 (1.1) |
| Delayed recall | 1.00 (1.2) | 1.20 (1.5) |
| Recognition | 15.40 (1.8) | 17.00 (1.5) |
| Visual memory (WMS-IV) | ||
| Short term | 7.80 (5.2) | 14.40 (10.2) |
| Long term | 0.60 (1.3) | 5.60 (6.1) |
| Recognition | 1.40 (1.6) | 2.80 (1.1) |
| Executive function | ||
| Stroop test inhibition | 11.40 (7.8) | 17.25 (7.1) |
| Phonemic fluency | 7.60 (4.5) | 7.40 (4.6) |
| Language | ||
| Semantic fluency | 6.40 (2.3) | 8.20 (3.3) |
| BNT | 46.00 (7.2) | 46.50 (7.8) |
| Visuospatial function | ||
| JLO | 10.4 (10.1) | 13.8 (10.4) |
| VOSP silhouettes | 16.6 (4.4) | 19.6 (2.5) |
| Neuropsychiatric scales | ||
| GDS | 12.4 (5.9) | 13.4 (5.5) |
| NPI | 5.4 (3.4) | 4.2 (3.1) |
Data are presented as mean and standard deviation.
MMSE mini-mental state examination, MoCA Montreal Cognitive Assessment, CERAD Consortium to Establish a Registry for Alzheimer’s Disease, WMS Wechsler Memory Scale, BNT Boston Naming test, JLO Judgment of Line Orientation, VOSP Visual Object and Space Perception, GDS Geriatric Depression Scale, NPI Neuropsychiatric inventory.